收藏切换
Introduction and comparison of guidelines for bioequivalence evaluation of inhalants
收藏切换
Qin-lei ZHOU1, 2, Yan-ping GUAN3, Xiao-lin LIU1, 2, Min HUANG1, 2, Guo-ping ZHONG1, 2
Chinese Journal of New Drugs | 2021, 30(3) : 197 - 204
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(3): 197-204
Introduction and comparison of guidelines for bioequivalence evaluation of inhalants
Full
Qin-lei ZHOU1, 2, Yan-ping GUAN3, Xiao-lin LIU1, 2, Min HUANG1, 2, Guo-ping ZHONG1, 2
Affiliations
  • 1Data Management Center of Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510080, China
  • 2Guangdong Engineering Technology Research Center of Quality Consistency Evaluation for Generic Drugs, Guangzhou 510080, China
  • 3Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Guangzhou 510080, China
Published: 2021-02-15
Outline
收藏切换

Compared with ordinary preparations, inhalants have special characteristics in terms of dosage form, device and mode of action. If the bioequivalence evaluation of inhalation is carried out according to the evaluation method of ordinary preparations, the accuracy of obtained results may be reduced. The bioequivalence evaluation of inhalation is facing challenges. At present, with the increasing market demand, domestic researches on inhalation preparations have also shown an upward trend; however, no domestic guidelines for bioequivalence evaluation of inhalation have been formally issued, bringing certain limitations to related researches. This article mainly introduces the guidelines and revised drafts of bioequivalence evaluation of inhalation preparations by the drug regulatory agencies of the United States, Europe and Canada, compared with the public solicitation of “Guidelines for the Research on Guiding Principles of Oral Inhalation Formulation Generic Pharmaceuticals and Human Bioequivalence Research” which is issued in August 2019 by Center for Drug Evaluation of National Medical Products Administration of China. Combined with specific cases, this article provides a scientific reference for the bioequivalence research of inhalation preparations in China.

inhalant  /  bioequivalence  /  guideline  /  evaluation
周沁蕾, 管宴萍, 刘晓琳, 黄民, 钟国平. 吸入剂生物等效性评价方法介绍与比较. 中国新药杂志, 2021 , 30 (3) : 197 -204 .
Qin-lei ZHOU, Yan-ping GUAN, Xiao-lin LIU, Min HUANG, Guo-ping ZHONG. Introduction and comparison of guidelines for bioequivalence evaluation of inhalants[J]. Chinese Journal of New Drugs, 2021 , 30 (3) : 197 -204 .
Year 2021 volume 30 Issue 3
26
6
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-29
  • Published:2021-02-15
Article Data
Affiliations
History
  • Accepted:2020-03-20
Funding
Affiliations
    1Data Management Center of Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510080, China
    2Guangdong Engineering Technology Research Center of Quality Consistency Evaluation for Generic Drugs, Guangzhou 510080, China
    3Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Guangzhou 510080, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT